103 related articles for article (PubMed ID: 6264939)
1. HLA frequency and prognosis in lung cancer.
Ford CH; Newman CE; Mackintosh P
Br J Cancer; 1981 May; 43(5):610-4. PubMed ID: 6264939
[TBL] [Abstract][Full Text] [Related]
2. Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5. A two-year prospective study.
Rogentine CN; Dellon AL; Chretien PB
Cancer; 1977 Jun; 39(6):2345-7. PubMed ID: 872033
[TBL] [Abstract][Full Text] [Related]
3. HLA antigens and bronchogenic carcinoma in the Greek population.
Toumbis M; Zervas J; Anagnostopoulou O; Konstantopoulos K; Krimbeni G; Kotsovoulou V; Fessas F
Acta Oncol; 1991; 30(5):575-8. PubMed ID: 1654063
[TBL] [Abstract][Full Text] [Related]
4. [The distribution of HLA-system antigens in lung cancer patients].
Levin VI; Muravskaia GV; Buglova EE; Semenov GV; Shavlikova LA; Surovikina VV; Sinaĭko VV
Vopr Onkol; 1991; 37(3):280-3. PubMed ID: 1851586
[TBL] [Abstract][Full Text] [Related]
5. HLA type and survival in lung cancer.
Weiss GB; Nawrocki LB; Daniels JC
Cancer; 1980 Jul; 46(1):38-40. PubMed ID: 7388766
[TBL] [Abstract][Full Text] [Related]
6. HLA antigens and bronchogenic carcinoma.
Prazák J; Mĕricka O
Neoplasma; 1989; 36(5):599-602. PubMed ID: 2812153
[TBL] [Abstract][Full Text] [Related]
7. Histocompatibility antigen expression in pulmonary carcinomas as indication of differentiation and of special subtypes.
Dämmrich J; Müller-Hermelink HK; Mattner A; Buchwald J; Ziffer S
Cancer; 1990 May; 65(9):1942-54. PubMed ID: 2164874
[TBL] [Abstract][Full Text] [Related]
8. HLA and survival in lung cancer.
Mottironi VD; Banks SM; Pollara B; Rudofsky UH
Clin Immunol Immunopathol; 1987 Oct; 45(1):55-62. PubMed ID: 3476226
[TBL] [Abstract][Full Text] [Related]
9. Histocompatibility antigens in small cell carcinoma of the lung.
Markman M; Braine HG; Abeloff MD
Cancer; 1984 Dec; 54(12):2943-5. PubMed ID: 6093986
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
[TBL] [Abstract][Full Text] [Related]
11. Histocompatibility locus antigens (HLA) in the epidermoid type of lung carcinoma.
Prazák J; Mĕricka O; Chytrý J
J Cancer Res Clin Oncol; 1990; 116(5):525-7. PubMed ID: 2229145
[TBL] [Abstract][Full Text] [Related]
12. The study of tumor necrosis factor beta gene polymorphism in lung cancer patients.
Shimura T; Hagihara M; Takebe K; Munkhbat B; Odaka T; Kato H; Nagamachi Y; Tsuji K
Cancer; 1994 Feb; 73(4):1184-8. PubMed ID: 8313320
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.
Nissen MH; Plesner T; Larsen JK; Olesen BK; Ernst P
Clin Exp Immunol; 1985 Feb; 59(2):327-35. PubMed ID: 2983911
[TBL] [Abstract][Full Text] [Related]
14. Severe hypertension in the Spanish population. Association with specific HLA antigens.
Luque Otero M; Martell Claros N; Llorente Pérez L; Fernández Pinilla C; Fernández-Cruz A
Hypertension; 1983; 5(6 Pt 3):V149-52. PubMed ID: 6581125
[TBL] [Abstract][Full Text] [Related]
15. No association between HLA antigens and adenocarcinoma of the lung in non-smoking Chinese women in Hong Kong.
Lam WK; Hawkins BR; Kung IT; So SY
Br J Dis Chest; 1986 Oct; 80(4):370-4. PubMed ID: 3476147
[TBL] [Abstract][Full Text] [Related]
16. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of early bronchogenic carcinoma. Survival curves of 451 patients after resection of lung cancer in relation to the results of pre-operative tuberculin skin test.
Israel L; Mugica J; Chahinian P
Biomedicine; 1973 Feb; 19(2):68-72. PubMed ID: 4354467
[No Abstract] [Full Text] [Related]
18. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
Doyle A; Martin WJ; Funa K; Gazdar A; Carney D; Martin SE; Linnoila I; Cuttitta F; Mulshine J; Bunn P
J Exp Med; 1985 May; 161(5):1135-51. PubMed ID: 2580935
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte A and B antigens in patients with prostatic adenocarcinoma.
Barry JM; Goldstein A; Hubbard M
J Urol; 1980 Dec; 124(6):847-8. PubMed ID: 7441836
[TBL] [Abstract][Full Text] [Related]
20. Does the location of lung cancer affect its prognosis?
Huhti E; Saloheimo M; Sutinen S; Reinilä A
Eur J Respir Dis; 1983 Aug; 64(6):460-5. PubMed ID: 6309544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
